These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1095022)

  • 1. Selective suppression of autoantibody responses in NZB/NZW mice treated with long-term cyclophosphamide.
    Walker SE; Bole GG
    Arthritis Rheum; 1975; 18(3):265-72. PubMed ID: 1095022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressed hetergeneous antinuclear antibody response in lymphomabearing NZB/NZW mice.
    Walker SE; Bole GG
    Clin Exp Immunol; 1976 Apr; 24(1):210-7. PubMed ID: 1084817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated appearance of neoplasms in female NZB/NZW mice treated with high-dose cyclophosphamide.
    Walker SE; Anver MR
    Arthritis Rheum; 1979 Dec; 22(12):1338-43. PubMed ID: 391238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of neoplasms in female NZB/NZW mice treated with pulse doses of cyclophosphamide.
    Walker SE; Anver MR
    Vet Immunol Immunopathol; 1983 Nov; 5(1):97-104. PubMed ID: 6606891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW)F1 hybrids.
    al-Balaghi S; Möller E; Möller G; Abedi-Valugerdi M
    Eur J Immunol; 1996 Jul; 26(7):1519-26. PubMed ID: 8766555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulated autoantibody response and increased longevity in NZB/NZW mice treated with cyclophosphamide and tilorone.
    Walker SE; Anver MR
    Clin Exp Immunol; 1978 Sep; 33(3):453-62. PubMed ID: 737897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro production of anti-histone antibodies by spleen cells from young autoantibody negative NZB/NZW mice.
    O'Dell JR; Kotzin BL
    J Immunol; 1985 Aug; 135(2):1101-7. PubMed ID: 3874228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of altered lymphocyte function on immunologic disorders in NZB/NZW mice.
    Mehta J; Knotts LL; Hahn BH
    Arthritis Rheum; 1977; 20(1):65-72. PubMed ID: 13801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early appearance of abnormally migrating serum IgM in control and cyclophosphamide-treated NZB/NZW mice.
    Walker SE
    J Rheumatol; 1982; 9(2):183-8. PubMed ID: 6980279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of development of anti-nuclear antibody and glomerulonephritis in NZB x NZWF1 mice by persistent infection with lactic dehydrogenase virus: possible involvement of superoxide anion as a progressive effector.
    Hayashi T; Noguchi Y; Kameyama Y
    Int J Exp Pathol; 1993 Dec; 74(6):553-60. PubMed ID: 8292553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease.
    Fournie GJ; Minh MG; Mignon-Conte MA; Hass S; Lambert PH; Conte JJ
    J Clin Lab Immunol; 1980 Sep; 4(2):103-6. PubMed ID: 7441709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependence of spontaneous delayed hypersensitivity to DNA, antinuclear antibody production and development of glomerulonephritis in NZB mice.
    Zitnan D; Rovenský J; Cebecauer L; Pekárek J; Svejcar J; Kopecký S
    Folia Biol (Praha); 1975; 21(4):234-7. PubMed ID: 1081054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribavirin treatment in murine autoimmune disease. I. Therapeutic efficacy and effect on the immune response.
    Klassen LW; Williams GW; Reinertsen JL; Gerber NL; Steinberg AD
    Arthritis Rheum; 1979 Feb; 22(2):145-54. PubMed ID: 33680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of immunosuppression on antinuclear antibody and survival of wehi mice.
    Rodger B; Whittingham S; Mackay IR
    Aust J Exp Biol Med Sci; 1975 Aug; 53(4):325-8. PubMed ID: 1084743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular basis of in vitro anti-DNA antibody production: evidence for T cell dependence of IgG-class anti-DNA antibody synthesis in the (NZB X NZW)F1 hybrid.
    Sekigawa I; Ishida Y; Hirose S; Sato H; Shirai T
    J Immunol; 1986 Feb; 136(4):1247-52. PubMed ID: 3484766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonality of the spontaneous immune response to DNA in murine lupus.
    Cavallo T; Granholm NA; Graves K; Izui S
    J Clin Lab Immunol; 1986 Jun; 20(2):81-7. PubMed ID: 3488408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levamisole maintains cyclophsophamide-induced remission in murine lupus erythematosus.
    Zulman J; Michalski J; McCombs C; Greenspan J; Talal N
    Clin Exp Immunol; 1978 Feb; 31(2):321-7. PubMed ID: 306328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated (NZB X NZW) F1 mice.
    Israel-Biet D; Noel LH; Bach MA; Dardenne M; Bach JF
    Clin Exp Immunol; 1983 Nov; 54(2):359-65. PubMed ID: 6360436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential effects of cyclophosphamide and 6-mercaptopurine on the renal disease and skin immunoglobulin deposits of the NZB-NZW F1 hybrid mice.
    Hurd ER; Gilliam JN; Ziff M
    Agents Actions; 1976 Feb; 6(1-3):364-8. PubMed ID: 782209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
    Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
    Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.